Morning Ireland podcast

Immunising infants and older people against RSV found to not be cost-effective - HIQA

0:00
2:54
Rewind 15 seconds
Fast Forward 15 seconds
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.

See omnystudio.com/listener for privacy information.

More episodes from "Morning Ireland"